Literature DB >> 20801091

Brain tumor stem cells: the cancer stem cell hypothesis writ large.

Peter B Dirks1.   

Abstract

Brain tumors, which are typically very heterogeneous at the cellular level, appear to have a stem cell foundation. Recently, investigations from multiple groups have found that human as well as experimental mouse brain tumors contain subpopulations of cells that functionally behave as tumor stem cells, driving tumor growth and generating tumor cell progeny that form the tumor bulk, but which then lose tumorigenic ability. In human glioblastomas, these tumor stem cells express neural precursor markers and are capable of differentiating into tumor cells that express more mature neural lineage markers. In addition, modeling brain tumors in mice suggests that neural precursor cells more readily give rise to full blown tumors, narrowing potential cells of origin to those rarer brain cells that have a proliferative potential. Applying stem cell concepts and methodologies is giving fresh insight into brain tumor biology, cell of origin and mechanisms of growth, and is offering new opportunities for development of more effective treatments. The field of brain tumor stem cells remains very young and there is much to be learned before these new insights are translated into new patient treatments.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20801091      PMCID: PMC5527933          DOI: 10.1016/j.molonc.2010.08.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  121 in total

1.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

2.  LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal.

Authors:  Alexandra Capela; Sally Temple
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

3.  NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Authors:  Xing Fan; Leila Khaki; Thant S Zhu; Mary E Soules; Caroline E Talsma; Naheed Gul; Cheryl Koh; Jiangyang Zhang; Yue-Ming Li; Jarek Maciaczyk; Guido Nikkhah; Francesco Dimeco; Sara Piccirillo; Angelo L Vescovi; Charles G Eberhart
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

4.  Separating stem cells by flow cytometry: reducing variability for solid tissues.

Authors:  Caroline M Alexander; Joel Puchalski; Kristine S Klos; Nisha Badders; Laurie Ailles; Carla F Kim; Peter Dirks; Matthew J Smalley
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

5.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

Authors:  Dagmar Beier; Peter Hau; Martin Proescholdt; Annette Lohmeier; Jörg Wischhusen; Peter J Oefner; Ludwig Aigner; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

6.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

7.  Notch promotes radioresistance of glioma stem cells.

Authors:  Jialiang Wang; Timothy P Wakeman; Justin D Lathia; Anita B Hjelmeland; Xiao-Fan Wang; Rebekah R White; Jeremy N Rich; Bruce A Sullenger
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

8.  Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.

Authors:  R Sutter; O Shakhova; H Bhagat; H Behesti; C Sutter; S Penkar; A Santuccione; R Bernays; F L Heppner; U Schüller; M Grotzer; H Moch; P Schraml; S Marino
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

9.  CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

Authors:  Dagmar Beier; Jörg Wischhusen; Wolfgang Dietmaier; Peter Hau; Martin Proescholdt; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

10.  Neuro-oncology: new hope for patients with gliomas.

Authors:  Lisa M Deangelis
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 59.935

View more
  65 in total

1.  Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells.

Authors:  Jehad Algharabil; Douglas B Kintner; Qiwei Wang; Gulnaz Begum; Paul A Clark; Sung-Sen Yang; Shih-Hua Lin; Kristopher T Kahle; John S Kuo; Dandan Sun
Journal:  Cell Physiol Biochem       Date:  2012-06-08

2.  Stem cells and cancer - the promise and puzzles.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  Mol Oncol       Date:  2010-07-27       Impact factor: 6.603

Review 3.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

4.  REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells.

Authors:  Anantha L Marisetty; Sanjay K Singh; Tran N Nguyen; Cristian Coarfa; Bin Liu; Sadhan Majumder
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

5.  USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.

Authors:  Jin-Ku Lee; Nakho Chang; Yeup Yoon; Heekyoung Yang; Heejin Cho; Eunhee Kim; Yongjae Shin; Wonyoung Kang; Young Taek Oh; Gyeong In Mun; Kyeung Min Joo; Do-Hyun Nam; Jeongwu Lee
Journal:  Neuro Oncol       Date:  2015-06-01       Impact factor: 12.300

Review 6.  NOS Expression and NO Function in Glioma and Implications for Patient Therapies.

Authors:  Anh N Tran; Nathaniel H Boyd; Kiera Walker; Anita B Hjelmeland
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

7.  Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma.

Authors:  Hongtao Zhang; Chengfei Hao; Haibo Wang; Haitao Shang; Zhonglian Li
Journal:  Int J Exp Pathol       Date:  2019-05-06       Impact factor: 1.925

8.  Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.

Authors:  Franz J Zemp; Xueqing Lun; Brienne A McKenzie; Hongyuan Zhou; Lori Maxwell; Beichen Sun; John J P Kelly; Owen Stechishin; Artee Luchman; Samuel Weiss; J Gregory Cairncross; Mark G Hamilton; Brian A Rabinovich; Masmudur M Rahman; Mohamed R Mohamed; Sherin Smallwood; Donna L Senger; John Bell; Grant McFadden; Peter A Forsyth
Journal:  Neuro Oncol       Date:  2013-04-12       Impact factor: 12.300

9.  Impairment of stress granule assembly via inhibition of the eIF2alpha phosphorylation sensitizes glioma cells to chemotherapeutic agents.

Authors:  Fabrício de Almeida Souza Vilas-Boas; Aristóbolo Mendes da Silva; Lirlândia Pires de Sousa; Kátia Maciel Lima; Juliana Priscila Vago; Lucas Felipe Fernandes Bittencourt; Arthur Estanislau Dantas; Dawidson Assis Gomes; Márcia Carvalho Vilela; Mauro Martins Teixeira; Lucíola Silva Barcelos
Journal:  J Neurooncol       Date:  2016-01-05       Impact factor: 4.130

10.  Malignant transformation of bone marrow stromal cells induced by the brain glioma niche in rats.

Authors:  Qiuping He; Xifeng Zou; Deyi Duan; Yujun Liu; Qunyuan Xu
Journal:  Mol Cell Biochem       Date:  2015-11-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.